Literature DB >> 24095209

HRCT and MRI of the lung in children with cystic fibrosis: comparison of different scoring systems.

Chiara Sileo1, Harriet Corvol2, Pierre-Yves Boelle3, Eléonore Blondiaux1, Annick Clement4, Hubert Ducou Le Pointe1.   

Abstract

BACKGROUND: Chest imaging is essential in the assessment of respiratory disease in cystic fibrosis (CF). High-resolution computed tomography (HRCT) can detect progressive lung disease but involves significant delivered dose of ionizing radiation. Magnetic resonance imaging (MRI) is radiation-free but is rarely used in CF. Based on the limited information on the potential interest of chest MRI in CF pediatric patients, the aims of our study were: 1) to evaluate and compare the reproducibility of HRCT and MRI scores; and 2) to evaluate the agreement between HRCT and MRI scores using both Helbich and Eichinger scores.
METHODS: In this prospective study, CF children who were having a HRCT for their routine assessment were proposed to perform a chest MRI the same day. 17 patients were included (median age 12.7 years). Two radiologists scored independently HRCT (Helbich score) and MRI (Helbich and Eichinger scores); and established a consensus score. Concordance was assessed using the Intraclass Correlation Coefficient (ICC); and the inter-observer reproducibility between methods was compared using Fisher's Z test for dependent observations.
RESULTS: Concordance between readers was almost perfect for HRCT score (ICC = 96%) and MRI-Eichinger score (84%), and substantial for MRI-Helbich score (68%). Correlation was strong between HRCT and MRI (r = 0.86 and 0.91 for HRCT and respectively MRI-Eichinger and MRI-Helbich scores) and the concordance almost perfect and substantial (ICC = 86% and 78% for HRCT and respectively MRI-Eichinger and MRI-Helbich scores).
CONCLUSIONS: We showed that, in CF children, MRI could adequately visualize lung morphologic changes when compared with the "gold-standard" HRCT. Regarding the potential cancer risks from associated ionizing radiation with HRCT, these results lead us to propose larger intervals of time between two lung HRCTs with realization of lung MRI in the meantime.
© 2013.

Entities:  

Keywords:  Children; Cystic fibrosis; Lung HRCT; Lung MRI

Mesh:

Year:  2013        PMID: 24095209     DOI: 10.1016/j.jcf.2013.09.003

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  12 in total

Review 1.  Pediatric Chest MRI: A Review.

Authors:  Savinay Kapur; Ashu Seith Bhalla; Manisha Jana
Journal:  Indian J Pediatr       Date:  2019-02-05       Impact factor: 1.967

2.  A semiquantitative MRI-Score can predict loss of lung function in patients with cystic fibrosis: Preliminary results.

Authors:  Juergen F Schaefer; Andreas Hector; Katharina Schmidt; Matthias Teufel; Sabrina Fleischer; Ute Graepler-Mainka; Joachim Riethmueller; Sergios Gatidis; Susanne Schaefer; Konstantin Nikolaou; Dominik Hartl; Ilias Tsiflikas
Journal:  Eur Radiol       Date:  2017-06-29       Impact factor: 5.315

3.  MRI in Thoracic Tuberculosis of Children.

Authors:  Kushaljit Singh Sodhi; Madhurima Sharma; Akshay Kumar Saxena; Joseph L Mathew; Meenu Singh; Niranjan Khandelwal
Journal:  Indian J Pediatr       Date:  2017-06-10       Impact factor: 1.967

4.  Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution.

Authors:  Gaël Dournes; Fanny Menut; Julie Macey; Michaël Fayon; Jean-François Chateil; Marjorie Salel; Olivier Corneloup; Michel Montaudon; Patrick Berger; François Laurent
Journal:  Eur Radiol       Date:  2016-02-02       Impact factor: 5.315

Review 5.  Current state of the art MRI for the longitudinal assessment of cystic fibrosis.

Authors:  Jason C Woods; Jim M Wild; Mark O Wielpütz; John P Clancy; Hiroto Hatabu; Hans-Ulrich Kauczor; Edwin J R van Beek; Talissa A Altes
Journal:  J Magn Reson Imaging       Date:  2019-12-17       Impact factor: 4.813

Review 6.  Interstitial Lung Disease in Childhood: Clinical and Genetic Aspects.

Authors:  Hiroshi Kitazawa; Shigeo Kure
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-10-11

7.  Brazilian guidelines for the diagnosis and treatment of cystic fibrosis.

Authors:  Rodrigo Abensur Athanazio; Luiz Vicente Ribeiro Ferreira da Silva Filho; Alberto Andrade Vergara; Antônio Fernando Ribeiro; Carlos Antônio Riedi; Elenara da Fonseca Andrade Procianoy; Fabíola Villac Adde; Francisco José Caldeira Reis; José Dirceu Ribeiro; Lídia Alice Torres; Marcelo Bicalho de Fuccio; Matias Epifanio; Mônica de Cássia Firmida; Neiva Damaceno; Norberto Ludwig-Neto; Paulo José Cauduro Maróstica; Samia Zahi Rached; Suzana Fonseca de Oliveira Melo
Journal:  J Bras Pneumol       Date:  2017 May-Jun       Impact factor: 2.624

Review 8.  Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis.

Authors:  Jürgen Schäfer; Matthias Griese; Ravishankar Chandrasekaran; Sanjay H Chotirmall; Dominik Hartl
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

Review 9.  Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis.

Authors:  Mirjam Stahl; Eva Steinke; Marcus A Mall
Journal:  Genes (Basel)       Date:  2021-05-25       Impact factor: 4.096

Review 10.  Lung function imaging methods in Cystic Fibrosis pulmonary disease.

Authors:  Magdalena Kołodziej; Michael J de Veer; Marian Cholewa; Gary F Egan; Bruce R Thompson
Journal:  Respir Res       Date:  2017-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.